14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
AMDY vs MRNY: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, YieldMax MRNA Option Income Strategy ETF (MRNY) is the stronger overall head-to-head candidate over YieldMax AMD Option Income Strategy ETF (AMDY) in the Tradestie Institutional Equity Comparison Engine, winning 2–1 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). AMDY carries a Unified Composite Score of 49.8/100 (HOLD) at $40.01 (N/M Forward P/E, N/A operating margin), whereas MRNY carries 33.1/100 (SELL) at $37.68 (N/M Forward P/E, N/A operating margin).
Composite vs. Pillar Nuance: While AMDY currently prints a higher short-term Unified Composite Score (49.8/100 HOLD vs. MRNY 33.1/100 SELL), MRNY captures the overall institutional head-to-head verdict (2–1 matrix metrics and 0–0 across the 6 pillars) due to superior fundamental profitability (N/A vs. N/A operating margin) and revenue trajectory (N/A vs. N/A YoY).
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AMDY vs MRNY. Trailing 12-month operating profitability (AMDY N/A vs MRNY N/A) and valuation multiples (AMDY N/M vs MRNY N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ AMDY vs MRNY Key Questions & Quantitative Answers
As of Nov 16, 2026, YieldMax MRNA Option Income Strategy ETF (MRNY) is the stronger overall head-to-head candidate over YieldMax AMD Option Income Strategy ETF (AMDY) in the Tradestie Institutional Equity Comparison Engine, winning 2–1 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). AMDY carries a Unified Composite Score of 49.8/100 (HOLD) at $40.01 (N/M Forward P/E, N/A operating margin), whereas MRNY carries 33.1/100 (SELL) at $37.68 (N/M Forward P/E, N/A operating margin). Composite vs. Pillar Nuance: While AMDY currently prints a higher short-term Unified Composite Score (49.8/100 HOLD vs. MRNY 33.1/100 SELL), MRNY captures the overall institutional head-to-head verdict (2–1 matrix metrics and 0–0 across the 6 pillars) due to superior fundamental profitability (N/A vs. N/A operating margin) and revenue trajectory (N/A vs. N/A YoY).
AMDY and MRNY split Growth & Scale metrics: AMDY posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with MRNY at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, AMDY generates N/A in USD-normalized revenue versus N/A for MRNY. In operating R&D and SG&A reinvestment, AMDY deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for MRNY.
AMDY and MRNY trade at balanced relative valuation multiples. AMDY trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas MRNY trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against AMDY (N/A ROE) versus MRNY (N/A ROE) capital efficiency.
In options market volatility and institutional positioning, AMDY carries 27.0% implied volatility (19th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (3.16β · 115% Vol realized risk). By comparison, MRNY carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.88β · 90% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.